News

Bausch + Lomb Partners with GRF to Combat Glaucoma Awareness

Bausch + Lomb Partners with GRF to Combat Glaucoma Awareness

Bausch + Lomb Partners with Glaucoma Research Foundation for a Cause

Bausch + Lomb Corporation (NYSE/TSX: BLCO) is stepping up to raise awareness for glaucoma with the launch of the second annual “Faces of Glaucoma” campaign. This global eye health leader, dedicated to enhancing sight, is joining hands with the Glaucoma Research Foundation (GRF), a respected nonprofit striving to cure glaucoma. Together, they aim to spotlight compelling stories from patients to shine a light on this major health issue.

Understanding Glaucoma and Its Impact

Glaucoma is the second leading cause of blindness worldwide, impacting millions. Alarmingly, it's estimated that around half of those who have glaucoma are unaware of their condition. Andrew Stewart, president of Global Pharmaceuticals and International Consumer at Bausch + Lomb, emphasized this point: "There’s a critical need for ongoing education and awareness about glaucoma to help people recognize their risk and see an eye care professional." Throughout the month dedicated to glaucoma awareness, they are committed to educating the public and encouraging proactive management of eye health.

Engaging the Community through Personal Stories

Throughout January, this campaign will share powerful stories from individuals and families living with glaucoma to elevate understanding of the disease. Bausch + Lomb is also excited to announce a fundraising challenge, continuing their tradition for the fourth consecutive year, where contributions made will be matched up to $20,000. This funding will support GRF's essential research initiatives aimed at finding a cure for glaucoma.

Recognizing the Symptoms and Importance of Regular Eye Exams

Glaucoma can be sneaky, developing slowly and often without noticeable symptoms until significant damage occurs. It is vital to prioritize eye health by undergoing yearly comprehensive dilated eye exams. Although no definitive cure exists yet, early detection and intervention can significantly delay disease progression, with treatments such as prescription eye drops proving effective.

Broadening the Perspective on Glaucoma

This campaign is not only about education but also about inclusivity. Thomas M. Brunner, president & CEO of the Glaucoma Research Foundation, highlights the diversity in glaucoma's impact, stating, “While often associated with older adults, glaucoma can affect anyone irrespective of age, race, or gender. We aim to illustrate this diversity through our campaign.” The stories being shared are designed to resonate with various audiences and promote awareness on a broader scale.

About Glaucoma and Its Implications

Glaucoma is a chronic condition characterized by increased eye pressure that can lead to damage of the optic nerve, ultimately resulting in vision loss or blindness. With about four million people affected in the United States, it is crucial to catch the disease early to slow its progression. Awareness campaigns such as this are an essential step in helping those at risk understand their condition and seek the necessary care.

About Bausch + Lomb: A Leader in Eye Health

Bausch + Lomb stands at the forefront of eye health solutions, committed to preserving and enhancing vision across the lifespan. With a vast portfolio of around 400 products that include contact lenses, ophthalmic pharmaceuticals, and surgical instruments, they continue to play a pivotal role in the industry. Founded in 1853, the company boasts a strong research, development, and manufacturing base, employing approximately 13,000 people worldwide.

About Glaucoma Research Foundation: Pioneering Research and Education

The Glaucoma Research Foundation, established in 1978, is the oldest organization focused solely on eradicating glaucoma. This foundation has a history of leading impactful research and creating vital educational resources that aid in raising awareness and providing information to the public. Their website serves countless individuals seeking resources and support related to glaucoma.

Frequently Asked Questions

1. What is the purpose of the Faces of Glaucoma campaign?

The campaign aims to raise awareness about glaucoma and promote education through personal stories from individuals affected by the disease.

2. How can I participate in the fundraising challenge?

You can contribute to the challenge by donating funds which will be matched by Bausch + Lomb up to $20,000.

3. What are the symptoms of glaucoma?

Symptoms may develop gradually and include vision changes that often go unnoticed until considerable damage has occurred.

4. How can glaucoma be diagnosed?

A glaucoma diagnosis typically occurs through a comprehensive dilated eye exam conducted by an eye care professional.

5. How does Bausch + Lomb support eye health?

Bausch + Lomb provides a range of products aimed at improving and maintaining eye health, along with education initiatives such as the Faces of Glaucoma campaign.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 5

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

Knowtex Partners with Veterans Affairs to Enhance Healthcare AI

Updated Category News Views 288

Knowtex Partners with U.S. Department of Veterans Affairs Women-founded, YC-backed company, Knowtex brings ambient AI to the nation's largest integrated healthcare system SAN FRANCISCO — Knowtex, a frontrunner in ambient clinical intelligence, has secured a substantial contract with the U.S. Department of Veterans Affairs (VA) valued at $15 million. This achievement...

Continue Reading
Understanding Market Sentiment: A Deep Dive into Upstart Holdings

Updated Category News Views 101

Market Sentiment Around Upstart Holdings Inc Recently, Upstart Holdings Inc (NYSE: UPST) has witnessed a notable change in its short interest, which measures the percentage of shares sold short compared to the total float. The latest report indicates a reduction of 6.38% in this figure, resulting in approximately 23.62 million shares being sold short. This equates to...

Continue Reading
Husqvarna's Nomination Committee Proposes Exciting Board Changes

Updated Category News Views 152

Exciting Changes Ahead for Husqvarna AB's Board of Directors The Nomination Committee of Husqvarna AB is gearing up for the company's annual general meeting, proposing significant changes to its Board of Directors. Recently, it was announced that three members will not seek re-election, paving the way for fresh leadership and diverse perspectives. This move reflects the...

Continue Reading
Mirantis Unveils Advanced OpenStack for Kubernetes Solution

Updated Category News Views 166

Mirantis OpenStack for Kubernetes 24.3 Released Mirantis, a provider of open-source software that gives organizations comprehensive control over their infrastructure, has recently announced the launch of Mirantis OpenStack for Kubernetes (MOSK) 24.3. This latest version stands out as the first to deliver enterprise-grade OpenStack Caracal, specifically crafted to cater to...

Continue Reading
Bullish Trends in DoorDash Options: What Investors Need to Know

Updated Category News Views 154

Understanding DoorDash's Recent Options Activity Heavyweight investors are demonstrating a bullish stance towards DoorDash (NASDAQ: DASH). This shift in sentiment should draw the attention of market players. Insights gathered from our observations reveal a notable surge in options activity surrounding DASH. Recent Trading Insights On our watch, there have been 23...

Continue Reading